GGrantIndex
Sort

40,608 grants matching prostate cancer

Postdoctoral Training Program in Cancer Epidemiology

$498,538
Susan M Gapstur · Northwestern University At Chicago · R25 · FY2007 · CA

A MOUSE MODEL FOR PROSTATE CANCER

$498,535
Univ Of Med/Dent Nj-R W Johnson Med Sch · U01 · FY2002 · CA

Alpha-Adrenoceptors in Vascular Wall Growth

$498,443
James E Faber · Univ Of North Carolina Chapel Hill · R01 · FY2009 · HL

Early Detection Research Network (EDRN) Biomarker Reference Laboratory

$498,374
Cdfm-A, Michael Creenan · National Cancer Institute · Y01 · FY2022 · CA

Cancer Center Support Grant

$498,265
Michael A Caligiuri · Ohio State University · P30 · FY2016 · CA

Tumor Growth and Microenvironment Influence T Cell Tolerance to Tumor Antigens

$498,243
Arthur Hurwitz · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA

Detection of Prostate Cancer Genomic Signatures in Blood

$498,123
Amin I Kassis · Harvard Medical School · RC1 · FY2010 · CA

Molecular Targets for Cancer Detection and Treatment

$498,117
William George Nelson · Johns Hopkins University · T32 · FY2015 · CA

R-spondins, Secreted Frizzled-Related Proteins and the Regulation of Wnt Signali

$498,109
Jeffrey Rubin · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA

Case Control Study of Pancreas Cancer in Shanghai, China

$498,023
Harvey A Risch · Yale University · R01 · FY2012 · CA

A Combination Therapy to Treat Cancer-Related Fatigue

$498,007
Sriram Yennu · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA

Early Detection Research Network (EDRN) Biomarker Reference Laboratory

$498,000
Cdfm-A, Michael Creenan · National Cancer Institute · Y01 · FY2019 · CA

Hypothermic Storage and Cryopreservation of Corneas

$498,000
J M Baust · Cell Preservation Services, Inc. · R44 · FY2009 · EY

Near-Infrared Quantum Dots for In Vivo Imaging

$497,992
Beth Israel Deaconess Medical Center · R33 · FY2004 · EB

Control of lethal prostate cancer with a bispecific av and a5b1 integrin antibody

$497,984
Paul Mathew · Tufts Medical Center · R01 · FY2023 · CA

Role and targeting of PRMT5 in prostate cancer

$497,903
Chang-Deng Hu · Purdue University · R01 · FY2019 · CA

New Tools for Prostate Cancer Detection and Prognostication

$497,815
Sanjiv S Gambhir · Stanford University · U01 · FY2014 · CA

UDP-GLUCURONOSYLTRANSFERASE GENOTYPE AND CANCER RISK

$497,789
Philip Lazarus · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2009 · DE

Early Detection Research Network (EDRN) Biomarker Reference Laboratory

$497,767
Cdfm-A, Michael Creenan · National Cancer Institute · Y01 · FY2021 · CA

Molecular Dissection of Benign Prostatic Hyperplasia

$497,753
Brigham And Women'S Hospital · U01 · FY2003 · AG

Early Detection Research Network (EDRN) Biomarker Reference Laboratory

$497,703
Cdfm-A, Michael Creenan · National Cancer Institute · Y01 · FY2020 · CA

Comprehensive characterization of prostate stromal gene expression and association with lethal prostate cancer

$497,668
Kathryn L Penney · Brigham And Women'S Hospital · R37 · FY2020 · CA

Translation and Evaluation of a Multiparametric Prostate Cancer 3T Exam

$497,610
John Kurhanewicz · University Of California, San Francisco · R01 · FY2012 · CA

Mitochondrial Hsp90 chaperones and prostate cancer therapy

$497,511
Dario C. Altieri · Wistar Institute · P01 · FY2013 · CA

MBSR Symptom Cluster Trial for Breast Cancer Survivors

$497,507
Cecile A Lengacher · University Of South Florida · R01 · FY2011 · CA